Atlas Trials

Failure of First-Line Treatment That Included an Approved Anti PD-(L)1 Compound

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Failure of First-Line Treatment That Included an Approved Anti PD-(L)1 Compound

RecordFirmDate
Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure (NCT07219459)CatalYm GmbH2026-03-19

Track Failure of First-Line Treatment That Included an Approved Anti PD-(L)1 Compound automatically

Every clearance here is in the API, with alerts when new ones post.